Lipoprotein Lipase (LPL) (C-Term) Peptid
LPL
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN979546
Kurzübersicht für Lipoprotein Lipase (LPL) (C-Term) Peptid (ABIN979546)
Target
Lipoprotein Lipase (LPL)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequenz
- LGYEINKVRA KRSSKMYLKT RSQMPYKVFH YQVKIHFSGT ESETHTNQAF
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LPL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Lipoprotein Lipase (LPL)
-
Hintergrund
-
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alias Symbols: HDLCQ11, LIPD
Protein Interaction Partner: APOC2,ASCC2,CALR,CETP,COPS6,KIAA1377,LPL,LRP1,LRP2,LUC7L2,PTPN4,RPL18A,UBE2Z,VLDLR,ASCC2,COPS6,EMD,KIAA1377,LRP1,LRP2,LUC7L2,PLK1,PTPN4,RPL18A,UBE2Z,VLDLR
Protein Size: 475 -
Molekulargewicht
- 50 kDa
-
Gen-ID
- 4023
-
NCBI Accession
- NM_000237, NP_000228
-
UniProt
- P06858
Target
-
Sie sind hier:
